FindTrial
Sign In

serratus anterior plane block on postoperative analgesic effects of thoracoscope lung cancer radical

serratus anterior plane block on postoperative analgesic effects of thoracoscope lung cancer radical

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800016525
Enrollment
Unknown
Registered
2018-06-06
Start date
2018-07-01
Completion date
Unknown
Last updated
2018-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Two groups:injecte 20ml ropivacaine 0.5% on serratus anterior plane

Sponsors

Shengjing Hospital Affiliated to China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: ASA I-III; Aged 18 to 65 years old; BMI 18 to 25 kg/m2; Elective general anesthesia thoracoscope lung cancer radical prostatectomy

Exclusion criteria

Exclusion criteria: Preoperative has a history of opioids and other painkillers to use; Chest secondary surgery patients; Local anesthetics allergic patients; Patients with systemic infection; Have a mental disorder language communication difficulties

Design outcomes

Primary

MeasureTime frame
Postoperative VAS score;—

Countries

China

Contacts

Public ContactLong Bo

Shengjing Hospital Affiliated to China Medical University

longb_27@163.com+86 18940259927

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026